Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes

Author: Frank F.M.   Petray P.B.   Cazorla S.I.   Munoz M.C.   Corral R.S.   Malchiodi E.L.  

Publisher: Elsevier

ISSN: 0264-410X

Source: Vaccine, Vol.22, Iss.1, 2003-12, pp. : 77-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content